SR7: N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide
SR7 is a Ligand Of Interest in 4BN5 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4BN5_SR7_I_1396 | 40% | 8% | 0.252 | 0.965 | 2.28 | 2.41 | 8 | 15 | 10 | 0 | 100% | 1 |
| 4BN5_SR7_E_1396 | 36% | 4% | 0.257 | 0.95 | 2.54 | 3.03 | 9 | 18 | 4 | 0 | 100% | 1 |
| 4BN5_SR7_J_1396 | 35% | 9% | 0.242 | 0.931 | 2 | 2.53 | 9 | 18 | 6 | 0 | 100% | 1 |
| 4BN5_SR7_F_1396 | 33% | 8% | 0.255 | 0.936 | 2.07 | 2.58 | 9 | 16 | 10 | 0 | 100% | 1 |
| 4BN5_SR7_C_1397 | 31% | 10% | 0.288 | 0.959 | 2.07 | 2.19 | 9 | 15 | 3 | 0 | 100% | 1 |
| 4BN5_SR7_L_1397 | 31% | 11% | 0.254 | 0.923 | 1.92 | 2.22 | 11 | 10 | 4 | 0 | 100% | 1 |
| 4BN5_SR7_B_1396 | 29% | 4% | 0.283 | 0.945 | 2.43 | 3.11 | 10 | 18 | 5 | 0 | 100% | 1 |
| 4BN5_SR7_G_1396 | 29% | 6% | 0.291 | 0.95 | 2.48 | 2.55 | 10 | 19 | 18 | 0 | 100% | 1 |
| 4BN5_SR7_A_1396 | 25% | 4% | 0.314 | 0.955 | 2.52 | 3.04 | 9 | 18 | 3 | 0 | 100% | 1 |
| 4BN5_SR7_H_1396 | 25% | 10% | 0.323 | 0.961 | 2.42 | 1.95 | 6 | 12 | 12 | 0 | 100% | 1 |
| 4BN5_SR7_K_1397 | 24% | 16% | 0.288 | 0.917 | 2.25 | 1.48 | 9 | 10 | 7 | 0 | 100% | 1 |
| 4BN5_SR7_D_1396 | 23% | 17% | 0.331 | 0.96 | 2.12 | 1.5 | 6 | 6 | 1 | 0 | 100% | 1 |
